#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13784	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2560	648.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1937	1937	T	873	T,G	872,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13784	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2560	648.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1671	1671	C	866	C,T	865,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23264	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4109	706.2	0	.	n	.	0	T695C	SNP	695	695	T	1364	1364	C	902	C,A	901,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23264	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4109	706.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2640	2640	C	873	C,A	872,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23264	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4109	706.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2714	2714	A	811	A,T,C	808,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23264	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4109	706.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3266	3266	C	825	C	825	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1868	folP	855	855	100.0	folP.l6.c4.ctg.1	2032	114.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1286	1288	AGC	185;184;185	A;G;C,T	185;184;184,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4400	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4014	136.9	1	SNP	p	S91F	0	.	.	271	273	TCC	932	934	TCC	151;151;150	T;C;C	151;151;150	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4400	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4014	136.9	1	SNP	p	D95G	0	.	.	283	285	GAC	944	946	GAC	150;152;154	G;A;C,A	150;152;153,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4400	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4014	136.9	1	SNP	p	D95N	0	.	.	283	285	GAC	944	946	GAC	150;152;154	G;A;C,A	150;152;153,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1986	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1964	126.4	1	SNP	p	G45D	0	.	.	133	135	GGC	753	755	GGC	210;212;215	G;G;C	210;212;215	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1052	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1450	90.5	0	.	n	.	0	A197.	DEL	197	197	A	809	809	A	198	A	198	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4418	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3546	155.5	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1723	1725	ATC	209;208;208	A,T;T;C	208,1;208;208	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4418	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3546	155.5	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1876	1878	GCA	207;207;202	G,C;C,A;A	206,1;206,1;202	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4418	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3546	155.5	1	SNP	p	D86N	0	.	.	256	258	GAC	829	831	GAC	211;210;209	G;A,C;C	211;209,1;209	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4418	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3546	155.5	1	SNP	p	S87W	0	.	.	259	261	AGT	832	834	AGT	211;210;210	A;G;T,G	211;210;209,1	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4418	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3546	155.5	1	SNP	p	S87R	0	.	.	259	261	AGT	832	834	AGT	211;210;210	A;G;T,G	211;210;209,1	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4418	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3546	155.5	1	SNP	p	S87I	0	.	.	259	261	AGT	832	834	AGT	211;210;210	A;G;T,G	211;210;209,1	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4418	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3546	155.5	1	SNP	p	S88P	0	.	.	262	264	TCC	835	837	TCC	206;208;212	T,C;C;C,T	205,1;208;211,1	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3782	parE	1986	1986	100.0	parE.l15.c17.ctg.1	3204	147.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1784	1786	GGC	195;193;193	G;G;C	195;193;193	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	4046	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2881	175.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1552	1554	GCA	258;258;257	G,T,C;C;A	256,1,1;258;257	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4046	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2881	175.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1555	1557	ATC	260;257;256	A,G;T;C	259,1;257;256	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4046	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2881	175.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1567	1569	GTG	254;256;254	G;T;G	254;256;254	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4046	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2881	175.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1567	1569	GTG	254;256;254	G;T;G	254;256;254	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4046	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2881	175.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2071	2073	ACC	227;227;229	A;C,T;C	227;226,1;229	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4046	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2881	175.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2125	2127	GCG	220;221;220	G;C,T,G;G	219;218,1,1;220	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4046	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2881	175.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2125	2127	GCG	220;221;220	G;C,T,G;G	219;218,1,1;220	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4046	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2881	175.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2248	2250	GGC	218;221;222	G,T;G,C;C	217,1;220,1;222	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4046	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2881	175.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2257	2259	GGC	224;226;227	G,C;G;C	223,1;226;227	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4046	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2881	175.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2275	2277	CCG	226;231;232	C,T,A,G;C;G	223,1,1,1;231;232	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5424	ponA	2397	2397	99.87	ponA.l6.c17.ctg.1	3458	195.5	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1639	1641	ACG	226;225;227	A,G;C;G,A	224,2;225;226,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1962	porA	1146	1146	99.39	porA.l15.c4.ctg.1	2377	103.2	0	.	p	.	0	S22G	NONSYN	64	66	AGC	665	667	GGC	132;131;133	G,T;G;C	131,1;131;133	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1962	porA	1146	1146	99.39	porA.l15.c4.ctg.1	2377	103.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	847	847	C	143	C	143	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	0	.	p	.	0	T26A	NONSYN	76	78	ACC	645	647	GCC	270;270;270	G,C;C,T,A;C	269,1;268,1,1;270	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	0	.	p	.	0	K41D	NONSYN	121	123	AAA	690	692	GAC	287;287;286	G;A;C	287;287;286	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	996	998	CAA	268;269;271	C;A;A	268;269;271	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	1128	1130	CAA	294;294;293	C,A;A;A,T	293,1;294;292,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	0	.	p	.	0	N189S	NONSYN	565	567	AAC	1134	1136	AGC	286;295;295	A;G;C	286;295;295	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	0	.	p	.	0	I209M	NONSYN	625	627	ATC	1194	1196	ATG	260;258;256	A;T;G,C	259;258;255,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	0	.	p	.	0	.	MULTIPLE	632	633	GC	1202	1205	AGAT	261;262;264;265	A;G;A,G;T,G	261;262;263,1;264,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	0	.	p	.	0	Q213L	NONSYN	637	639	CAG	1209	1211	TTA	265;265;265	T;T;A	265;265;265	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	0	.	p	.	0	S216I	NONSYN	646	648	AGC	1218	1220	ATC	273;271;269	A;T;C	273;271;269	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	0	.	p	.	0	R256S	NONSYN	766	768	CGT	1338	1340	AGT	260;256;255	A;G,T;T	260;255,1;255	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1449	1451	AGT	234;235;234	A;G;T	234;235;234	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1455	1457	GAC	231;232;233	G;A;C	231;232;233	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	1	SNP	p	G120K	1	.	.	358	360	AAG	927	929	AAG	271;273;272	A;A;G,A	271;273;271,1	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	1	SNP	p	D121N	0	.	.	361	363	GAC	930	932	GAC	272;276;277	G;A;C	272;276;277	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3136	porB1b	1041	1041	97.7	porB1b.l15.c4.ctg.1	2107	185.2	1	SNP	p	A121D	1	.	.	361	363	GAC	930	932	GAC	272;276;277	G;A;C	272;276;277	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9940	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5412	229.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2284	2286	AAT	246;243;244	A;A;T,C	246;243;243,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1416	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1556	113.6	1	SNP	p	V57M	1	.	.	169	171	ATG	787	789	ATG	275;278;280	A;T;G	275;278;280	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
